Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Quinn

Showing results (571-580 of 635) with videos related to

Pageof 64
Sort By:
Parkinsonism & Related Disorders|February 27, 2018
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseBrenna Cholerton, Catherine O Johnson, Brian Fish, et al.
Movement Disorders Clinical Practice|May 7, 2020
Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear PalsyLawren VandeVrede, Marian L Dale, Scott Fields, et al.
The American Journal of Pathology|March 26, 2011
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophyYu Wang, Aneeka M Hancock, Joshua Bradner, et al.
Journal of Clinical Lipidology|July 19, 2018
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosisP Barton Duell, Gerald Salen, Florian S Eichler, et al.
Metabolites|April 21, 2022
Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidNathan Hwangbo, Xinyu Zhang, Daniel Raftery, et al.
Annals of Neurology|March 15, 2011
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionMin Shi, Joshua Bradner, Aneeka M Hancock, et al.
Journal of Extracellular Vesicles|September 1, 2015
Extracellular RNAs: development as biomarkers of human diseaseJoseph F Quinn, Tushar Patel, David Wong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2014
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceDaniel J Burdick, Brenna Cholerton, G S Watson, et al.
Brain : a Journal of Neurology|February 18, 2020
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tauEdward N Wilson, Michelle S Swarovski, Patricia Linortner, et al.
Biomaterials|May 9, 2022
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic painRocco Latorre, Paulina D Ramírez-Garcia, Alan Hegron, et al.
Pageof 64

Showing results (571-580 of 635) with videos related to

Sort By:
Pageof 64
Parkinsonism & Related Disorders|February 27, 2018
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseBrenna Cholerton, Catherine O Johnson, Brian Fish, et al.
Movement Disorders Clinical Practice|May 7, 2020
Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear PalsyLawren VandeVrede, Marian L Dale, Scott Fields, et al.
The American Journal of Pathology|March 26, 2011
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophyYu Wang, Aneeka M Hancock, Joshua Bradner, et al.
Journal of Clinical Lipidology|July 19, 2018
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosisP Barton Duell, Gerald Salen, Florian S Eichler, et al.
Metabolites|April 21, 2022
Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidNathan Hwangbo, Xinyu Zhang, Daniel Raftery, et al.
Annals of Neurology|March 15, 2011
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionMin Shi, Joshua Bradner, Aneeka M Hancock, et al.
Journal of Extracellular Vesicles|September 1, 2015
Extracellular RNAs: development as biomarkers of human diseaseJoseph F Quinn, Tushar Patel, David Wong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2014
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceDaniel J Burdick, Brenna Cholerton, G S Watson, et al.
Brain : a Journal of Neurology|February 18, 2020
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tauEdward N Wilson, Michelle S Swarovski, Patricia Linortner, et al.
Biomaterials|May 9, 2022
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic painRocco Latorre, Paulina D Ramírez-Garcia, Alan Hegron, et al.
Pageof 64